Neogenomics Inc.’s recently made public that its Officer ALICIA OLIVO acquired Company’s shares for reported $16453.0 on Aug 15 ’24. In the deal valued at $15.82 per share,1,040 shares were bought.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, BRUCE K CROWTHER bought 8,353 shares, generating $133,243 in total proceeds.
Before that, Olivo Alicia C sold 1,049 shares. Neogenomics Inc. shares valued at $16,511 were divested by the General Counsel at a price of $15.74 per share. As a result of the transaction, Olivo Alicia C now holds 44,867 shares, worth roughly $0.73 million.
A number of analysts have revised their coverage, including BTIG Research’s analysts, who remained covering the stock and in late December has reiterated a ‘”a Buy”‘ rating for it. Stephens also remained covering NEO and has increased its forecast on August 21, 2023 with a “an Overweight” recommendation from previously “an Equal-weight” rating. Raymond James revised its rating on May 16, 2023. It rated NEO as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of NEO
On Friday, Neogenomics Inc. [NASDAQ:NEO] saw its stock jump 0.37% to $16.18. Over the last five days, the stock has lost -2.24%. Nevertheless, the stocks have risen 17.76% over the past one year. While a 52-week high of $21.22 was reached on 07/31/24, a 52-week low of $11.03 was recorded on 06/10/24. SMA at 50 days reached $14.68, while 200 days put it at $15.57.
Levels Of Support And Resistance For NEO Stock
The 24-hour chart illustrates a support level at 16.04, which if violated will result in even more drops to 15.91. On the upside, there is a resistance level at 16.35. A further resistance level may holdings at 16.53. The Relative Strength Index (RSI) on the 14-day chart is 53.89, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.52, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 80.77%. Stochastics%K at 33.84% indicates the stock is a holding.
How much short interest is there in Neogenomics Inc.?
A steep rise in short interest was recorded in Neogenomics Inc. stocks on 2024-07-31, dropping by -0.63 million shares to a total of 4.88 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 5.51 million shares. There was a decline of -13.01%, which implies that there is a negative sentiment for the stock.
